论文信息 - Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model - 字舞流文

Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model

C. Spurr | E. Modest | H. Wells | V. Sethi | D. Jackson | M. Castle | J. Sterchi | W. Meredith | T. Long | D. Rosenbaum | M. L. Barringer

[1] V. Sethi,et al. A sensitive radioimmunoassay for vincristine and vinblastine , 2004, Cancer Chemotherapy and Pharmacology.

[2] F. Vassal,et al. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas , 2004, Cancer Chemotherapy and Pharmacology.

[3] C. Spurr,et al. Intravenous vincristine infusion: Phase I trial , 1981, Cancer.

[4] C. Spurr,et al. Pharmacokinetics of vincristine infusion. , 1981, Cancer treatment reports.

[5] H. Greenberg,et al. Implanted system for intraventricular drug infusion in central nervous system tumors. , 1981, Cancer treatment reports.

[6] J. Thrall,et al. Totally implanted drug delivery system for hepatic arterial chemotherapy. , 1981, Cancer treatment reports.

[7] G. Bodey,et al. Continuous infusion vindesine in solid tumors. , 1980, Cancer treatment reviews.

[8] G. Hortobagyi,et al. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. , 1980, Cancer treatment reports.

[9] P. Blackshear,et al. The implantable infusion pump: a new concept in drug delivery. , 1979, Medical progress through technology.

[10] R. Bender,et al. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. , 1979, Cancer research.